The complement cascade: new avenues in stroke therapy

Curr Vasc Pharmacol. 2009 Jul;7(3):287-92. doi: 10.2174/157016109788340677.

Abstract

Recent evidence has shown that after the initial occlusion, a large portion of stroke patients achieve some degree of reperfusion either through collateral circulation or clot dissolution. However, it appears that this reperfusion may lead to increased inflammation-induced damage. Even though the exact mechanism of this secondary injury is unclear, several experimental studies have indicated an intimate connection between complement and this secondary form of damage. We review the available literature and attempt to identify promising clinical therapeutic targets.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / physiopathology
  • Complement Activation / drug effects*
  • Complement Activation / physiology
  • Complement Inactivating Agents / therapeutic use*
  • Disease Models, Animal
  • Humans
  • Models, Biological
  • Neurogenesis / drug effects
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / physiopathology
  • Stroke / complications
  • Stroke / drug therapy*
  • Stroke / physiopathology

Substances

  • Complement Inactivating Agents